PAVmed, Inc. (PAVM)
2.79
+0.10
(+3.72%)
USD |
NASDAQ |
Oct 09, 16:00
2.79
0.00 (0.00%)
Pre-Market: 20:00
PAVmed Net Income (Quarterly) : -6.598M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.598M |
| March 31, 2026 | -1.064M |
| December 31, 2025 | -2.757M |
| September 30, 2025 | -6.011M |
| June 30, 2025 | -12.32M |
| March 31, 2025 | 18.62M |
| December 31, 2024 | 1.142M |
| September 30, 2024 | 60.71M |
| June 30, 2024 | -14.91M |
| March 31, 2024 | -18.51M |
| December 31, 2023 | -17.41M |
| September 30, 2023 | -21.75M |
| June 30, 2023 | -17.89M |
| March 31, 2023 | -22.21M |
| December 31, 2022 | -24.57M |
| September 30, 2022 | -29.93M |
| June 30, 2022 | -29.10M |
| March 31, 2022 | -19.63M |
| December 31, 2021 | -19.68M |
| September 30, 2021 | -13.67M |
| June 30, 2021 | -12.67M |
| March 31, 2021 | -10.11M |
| December 31, 2020 | -9.259M |
| Date | Value |
|---|---|
| September 30, 2020 | -5.874M |
| June 30, 2020 | -5.844M |
| March 31, 2020 | -14.91M |
| December 31, 2019 | -6.554M |
| September 30, 2019 | -3.271M |
| June 30, 2019 | -3.739M |
| March 31, 2019 | -3.704M |
| December 31, 2018 | -6.922M |
| September 30, 2018 | -3.279M |
| June 30, 2018 | -5.146M |
| March 31, 2018 | -2.825M |
| December 31, 2017 | 0.8698M |
| September 30, 2017 | -5.129M |
| June 30, 2017 | -0.9897M |
| March 31, 2017 | -4.270M |
| December 31, 2016 | -1.710M |
| September 30, 2016 | -1.929M |
| June 30, 2016 | -1.315M |
| March 31, 2016 | -0.6969M |
| December 31, 2015 | -0.7308M |
| September 30, 2015 | -0.5389M |
| June 30, 2015 | -0.3606M |
| March 31, 2015 | -0.1463M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
| Baxter International, Inc. | 135.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.033M |
| Total Expenses (Quarterly) | 5.417M |
| EPS Diluted (Quarterly) | -0.8739 |
| Enterprise Value | 18.88M |
| Gross Profit Margin (Quarterly) | -327.3% |
| Profit Margin (Quarterly) | -19.99K% |
| Earnings Yield | -590.3% |
| Normalized Earnings Yield | -465.84 |